Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

421

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

October 31, 2013

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Uric Acid

1 gram dissolved in a vehicle containing 500 ml of 0'1% Lithium Carbonate and 5% Mannitol, IV (in the vein), single dose.

OTHER

Vehicle

Single intravenous infusion of a 500 ml vehicle containing 0'1% Lithium Carbonate and 5% Mannitol.

Trial Locations (10)

17007

Hospital Dr Josep Trueta, Girona

31008

Hospital de Navarra, Pamplona

47005

Hospital Clínico Universitario de Valladolid, Valladolid

02006

Hospital General Universitario de Albacete, Albacete

08916

Hospital Universitari Germans Trias i Pujol, Badalona

08025

Hospital de la Santa Creu y Sant Pau, Barcelona

08036

Hospital Clínic de Barcelona, Barcelona

Unknown

Hospital Universitari de Bellvitge, Bellvitge

08208

Corporació Sanitària del Parc Taulí, Sabadell

08221

Hospital Universitari Mútua de Terrassa, Terrassa

All Listed Sponsors
collaborator

Carlos III Health Institute

OTHER_GOV

lead

Angel Chamorro, MD

OTHER

NCT00860366 - Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter